Gill v Ethicon Sàrl (No 6)

In the Federal Court of Australia, the case of Gill v Ethicon Sàrl (No 6) involved a representative action on behalf of women who had been implanted with Ethicon polypropylene mesh devices intended for permanent implantation in the female pelvis. The case primarily focused on the adequacy of information and warnings provided by the respondents, Ethicon Sàrl, Ethicon, Inc., and Johnson & Johnson Medical Pty Ltd (JJM), regarding the risks associated with these medical devices. The court had to decide whether the information and warnings given were adequate or if they were misleading or deceptive. Additionally, the court needed to determine whether injunctive relief should be granted to prevent the respondents from supplying or marketing these devices without appropriate warnings.

The court held that the information and warnings provided by the respondents were inadequate and misleading or deceptive. The respondents failed to adequately disclose the risks associated with the chronic inflammatory response, the potential for severe complications, and the lack of predictability of adverse effects in patients. The court further ruled that the proposed injunction, which required the inclusion of a specific warning in the instructions for use and promotional material, would be effective in preventing misleading conduct. However, the court also noted that recent amendments to the Therapeutic Goods (Medical Devices) Regulations 2002 (Cth) required certain information to be included in cards and leaflets to be sent to surgeons and patients. Consequently, the court decided to limit the injunction to the inclusion of the proposed warning in the instructions for use of the devices, considering that the devices were manufactured overseas and supplied with identical instructions worldwide.

The final orders of the court mandated that the respondents could not supply, distribute, market, or promote any of the specified medical devices without including the required warnings in the patient information leaflets and instructions for use. The court set deadlines for filing notices of appeal and specified the definition of terms used in the orders. The injunction was to take effect after a certain period, providing the respondents time to comply with the new requirements. The court's decision aimed to ensure that women were adequately informed of the risks associated with the implantation of these medical devices, thereby protecting consumer rights and safety.